Vifor and Angion's ANG-3777 Fail to Meet its Primary and Secondary Endpoint for Patients with High-Risk Kidney Transplant
Shots: The P-III trial ev...
AstraZeneca Reports Results of Imfinzi in P-III TOPAZ-1 Trial as 1L Treatment for Advanced Biliary Tract Cancer
Shots: The P-III TOPAZ-1...
Moderna Reports Results of COVID-19 Vaccine in P-II/III KidCOVE Study for the Treatment of COVID-19
Shots: The P-II/III KidCO...
Agenus Reports the Withdrawal of BLA for Balstilimab to Treat Cervical Cancer
Shots: The company has re...
